Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Rosmarinic acid suppresses inflammation, angiogenesis, and improves paclitaxel induced apoptosis in a breast cancer model via NF3 κB-p53-caspase-3 pathways modulation

Marwa A. Mahmoud, Tark M. Okda, Gamal A. Omran, Mohammad M. Abd-Alhaseeb

. 2021 ; 19 (4) : 202-209.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc22007634

Rosmarinic acid is a natural polyphenolic compound that is found in different plant species and used for different medicinal purposes. This study aimed to investigate the chemo-preventive effect of rosmarinic acid and evaluate its antitumor efficacy alone or in combination with Paclitaxel in breast cancer mice model. Ehrlich induced mice mammary solid tumor model was used in the study. Mice were treated with oral rosmarinic acid and intraperitoneal Paclitaxel. Inflammation, angiogenesis, and apoptosis were checked. Enzyme linked immunosorbent assay (ELISA), quantitative real time PCR, and immunohistochemical methods were performed. Rosmarinic acid used prior to tumor induction suppressed NF-κB, TNF-α, vascular endothelial growth factor (VEGF) serum levels, and VEGF receptors. It also triggered apoptosis by restoring the levels of P53, Bcl-2, Bax, and caspase-3. Furthermore, in Ehrlich solid tumor mice, rosmarinic acid, and/or Paclitaxel significantly suppressed tumor growth with an increase in apoptotic markers P53 and Caspase-3 levels, and suppressed the Bcl2/Bax ratio. Rosmarinic acid exerted chemo-preventive and therapeutic potential alone or in combination with Paclitaxel. Moreover, rosmarinic acid targets numerous signaling pathways associated with breast cancer.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc22007634
003      
CZ-PrNML
005      
20220914103638.0
007      
ta
008      
220306s2021 xr da f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2021.024 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Mahmoud, Marwa A. $u Damanhour University, Faculty of Pharmacy, Department of Biochemistry, Behira, Egypt
245    10
$a Rosmarinic acid suppresses inflammation, angiogenesis, and improves paclitaxel induced apoptosis in a breast cancer model via NF3 κB-p53-caspase-3 pathways modulation / $c Marwa A. Mahmoud, Tark M. Okda, Gamal A. Omran, Mohammad M. Abd-Alhaseeb
504    __
$a Literatura
520    9_
$a Rosmarinic acid is a natural polyphenolic compound that is found in different plant species and used for different medicinal purposes. This study aimed to investigate the chemo-preventive effect of rosmarinic acid and evaluate its antitumor efficacy alone or in combination with Paclitaxel in breast cancer mice model. Ehrlich induced mice mammary solid tumor model was used in the study. Mice were treated with oral rosmarinic acid and intraperitoneal Paclitaxel. Inflammation, angiogenesis, and apoptosis were checked. Enzyme linked immunosorbent assay (ELISA), quantitative real time PCR, and immunohistochemical methods were performed. Rosmarinic acid used prior to tumor induction suppressed NF-κB, TNF-α, vascular endothelial growth factor (VEGF) serum levels, and VEGF receptors. It also triggered apoptosis by restoring the levels of P53, Bcl-2, Bax, and caspase-3. Furthermore, in Ehrlich solid tumor mice, rosmarinic acid, and/or Paclitaxel significantly suppressed tumor growth with an increase in apoptotic markers P53 and Caspase-3 levels, and suppressed the Bcl2/Bax ratio. Rosmarinic acid exerted chemo-preventive and therapeutic potential alone or in combination with Paclitaxel. Moreover, rosmarinic acid targets numerous signaling pathways associated with breast cancer.
650    17
$a nádory prsu $x farmakoterapie $7 D001943 $2 czmesh
650    _7
$a modely nemocí na zvířatech $7 D004195 $2 czmesh
650    _7
$a paclitaxel $x terapeutické užití $7 D017239 $2 czmesh
650    _7
$a cinnamáty $x farmakologie $x terapeutické užití $7 D002934 $2 czmesh
650    _7
$a kombinovaná farmakoterapie $7 D004359 $2 czmesh
650    _7
$a Ehrlichův tumor $x farmakoterapie $x imunologie $x patologie $7 D002286 $2 czmesh
650    _7
$a experimentální nádory $7 D009374 $2 czmesh
650    _7
$a výsledek terapie $7 D016896 $2 czmesh
650    _7
$a TNF-alfa $x účinky léků $7 D014409 $2 czmesh
650    _7
$a vaskulární endoteliální růstové faktory $x účinky léků $7 D042442 $2 czmesh
650    _7
$a myši $7 D051379 $2 czmesh
650    _7
$a laboratorní zvířata $7 D000830 $2 czmesh
650    _7
$a apoptóza $x účinky léků $7 D017209 $2 czmesh
700    1_
$a Okda, Tark M. $u Damanhour University, Faculty of Pharmacy, Department of Biochemistry, Behira, Egypt
700    1_
$a Omran, Gamal A. $u Damanhour University, Faculty of Pharmacy, Department of Biochemistry, Behira, Egypt
700    1_
$a Abd-Alhaseeb, Mohammad M. $u Damanhour University, Faculty of Pharmacy, Department of Pharmacology and Toxicology, Behira, Egypt
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 19, č. 4 (2021), s. 202-209 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/ $y stránka časopisu
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20220304160729 $b ABA008
991    __
$a 20220914103622 $b ABA008
999    __
$a ok $b bmc $g 1767395 $s 1158823
BAS    __
$a 3
BMC    __
$a 2021 $b 19 $c 4 $d 202-209 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK125 $d 20220913 $a NLK 2022-11/dk

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace